Cargando…

Serum Biomarkers for Inflammatory Bowel Disease

Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel therapeutic goal and biologicals are widely recognized, accurate assessment of disease and prediction of therapeutic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peng, Zhou, Gaoshi, Lin, Jingxia, Li, Li, Zeng, Zhirong, Chen, Minhu, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188783/ https://www.ncbi.nlm.nih.gov/pubmed/32391365 http://dx.doi.org/10.3389/fmed.2020.00123

Ejemplares similares

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
por: Chen, Rirong, et al.
Publicado: (2023)

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022)

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

Role of Rho GTPases in inflammatory bowel disease
por: Li, Xiaoling, et al.
Publicado: (2023)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Recent developments on BMPs and their antagonists in inflammatory bowel diseases
por: Xie, Zhuo, et al.
Publicado: (2023)

Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3
por: Li, Manying, et al.
Publicado: (2017)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
por: Tie, Yizhe, et al.
Publicado: (2023)

Surgical management of inflammatory bowel disease in China: a systematic review of two decades
por: Yu, Qiao, et al.
Publicado: (2016)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023)

Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models
por: Yang, Hongsheng, et al.
Publicado: (2019)

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice
por: Lin, Lihui, et al.
Publicado: (2022)

Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis
por: Yu, Qiao, et al.
Publicado: (2015)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis
por: Chen, Hongxin, et al.
Publicado: (2023)

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
por: Liu, Fang, et al.
Publicado: (2020)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)

Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
por: Chen, Rirong, et al.
Publicado: (2021)

Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease
por: Wang, Huiling, et al.
Publicado: (2016)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients
por: Lin, Sinan, et al.
Publicado: (2018)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Inflammatory bowel disease is causally related to irritable bowel syndrome: a bidirectional two-sample Mendelian randomization study
por: Ke, Haoran, et al.
Publicado: (2023)

Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease
por: Corsi, Fabio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uc6easrh16ee6e5ahckkh42aae